Wendy Cranfill

Wendy Cranfill is an experienced professional in the field of Manufacturing Science and Technology (MSAT), currently serving as Director of MSAT New Product Introduction at Bristol Myers Squibb since July 2020. Wendy has held several key positions at Bristol Myers Squibb, including Director of MSAT Automation, MES & Equipment Validation, and interim Director of Site Strategy and Business Operations. Prior to joining Bristol Myers Squibb, Wendy worked at Juno Therapeutics, Inc. as MSAT Manager for Automation, and at AstraZeneca as Manufacturing Manager for Technology (MES). Wendy's career began at Maxtor as a Technical Writer and progressed through roles at Amgen, where responsibilities included NPI MFG Specialist and Manufacturing Specialist. Wendy holds a degree from Washington State University, obtained between 1987 and 1991.